メタ情報
| meta description平均長 | 87.75 |
|---|
| OGPありページ数 | 33 |
|---|
| Twitterカードありページ数 | 33 |
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 101 |
|---|
| ページあたり内部リンク平均 | 92.52 |
|---|
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| our | 1 |
| discovery | 0.985374 |
| will | 0.985374 |
| drug | 0.928383 |
| antibody | 0.833778 |
| FRONTEO | 0.820516 |
| MoGRAA | 0.791203 |
| investors | 0.703299 |
| data | 0.68368 |
| platform | 0.64572 |
| Discovery | 0.644443 |
| GPCR | 0.641989 |
| has | 0.586083 |
| Engine | 0.530586 |
| DDAIF | 0.515769 |
| English | 0.51276 |
| Science | 0.51276 |
| Shirai | 0.51276 |
| protein | 0.51276 |
| science | 0.51276 |
| Event | 0.51276 |
| targeted | 0.5 |
| Center | 0.5 |
| Health | 0.468866 |
| Laboratory | 0.468866 |
| collaboration | 0.468866 |
| 当社は | 0.461229 |
| proprietary | 0.461229 |
| clinical | 0.412615 |
| global | 0.412615 |
| worldwide | 0.412615 |
| actively | 0.412615 |
| Drug | 0.412615 |
| Factory | 0.412615 |
| partnership | 0.412615 |
| companies | 0.412615 |
| Convention | 0.412615 |
| event | 0.412615 |
| Location | 0.412615 |
| company | 0.411111 |
| 実証実験 | 0.411111 |
| GPCRs | 0.411111 |
| technologies | 0.411111 |
| Boston | 0.411111 |
| Vienna | 0.411111 |
| Please | 0.35165 |
| antibodies | 0.35165 |
| research | 0.35165 |
| development | 0.35165 |
| following | 0.35165 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Health | Laboratory | 2.518572 | 16 |
| ご関心をお持ちの企業 | 投資家の皆様は | 2.432039 | 12 |
| encouraged | request | 2.432039 | 12 |
| Discovery | Engine | 2.408139 | 28 |
| DDAIF | Factory | 2.361252 | 16 |
| ご関心をお持ちの企業 | 製薬企業 | 2.29913 | 12 |
| Throughout | audience | 2.29913 | 12 |
| Throughout | convention | 2.29913 | 12 |
| investment | opportunities | 2.29913 | 12 |
| opportunities | pharmaceutical | 2.29913 | 12 |
| Individual | meetings | 2.29913 | 12 |
| can | meetings | 2.29913 | 12 |
| arranged | can | 2.29913 | 12 |
| arranged | via | 2.29913 | 12 |
| official | partnering | 2.29913 | 12 |
| partnering | system | 2.29913 | 12 |
| Companies | system | 2.29913 | 12 |
| interested | meeting | 2.29913 | 12 |
| meeting | warmly | 2.29913 | 12 |
| encouraged | warmly | 2.29913 | 12 |
| GPCR | targeted | 2.2813 | 24 |
| antibody | targeted | 2.2813 | 24 |
| language | news | 2.196968 | 9 |
| ぜひお声がけください | 投資家の皆様は | 2.158394 | 9 |
| appointment | request | 2.158394 | 9 |
| discovery | drug | 2.144918 | 28 |
| data | protein | 2.127779 | 12 |
| data | science | 2.127779 | 12 |
| clinical | pre | 2.127779 | 12 |
| clinical | pipeline | 2.127779 | 12 |
| global | pipeline | 2.127779 | 12 |
| audience | global | 2.127779 | 12 |
| actively | seek | 2.127779 | 12 |
| partnership | seek | 2.127779 | 12 |
| investment | partnership | 2.127779 | 12 |
| companies | pharmaceutical | 2.127779 | 12 |
| Individual | worldwide | 2.127779 | 12 |
| event | via | 2.127779 | 12 |
| event | official | 2.127779 | 12 |
| ご関心をお持ちの企業 | ぜひお声がけください | 2.046551 | 9 |
| appointment | encouraged | 2.046551 | 9 |
| 当社は | 自社独自の | 2.044533 | 12 |
| Nikkei | Online | 2.038242 | 8 |
| life | quality | 2.038242 | 8 |
| Discovery | MoGRAA | 2.00503 | 34 |
| language | tab | 1.989109 | 8 |
| been | have | 1.989109 | 8 |
| HOKKAIDO | Startup | 1.989109 | 8 |
| assumed | elected | 1.989109 | 8 |
| assumed | office | 1.989109 | 8 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録